IGFBP‑4 expression is adversely associated with lung cancer prognosis

  • Authors:
    • Yang Xiao
    • Shan Zhu
    • Wen Yin
    • Xiaofan Liu
    • Yi Hu
  • View Affiliations

  • Published online on: September 21, 2017     https://doi.org/10.3892/ol.2017.7014
  • Pages:6876-6880
Metrics: PDF 0 views | HTML 0 views
0

Abstract

Insulin‑like growth factor binding protein‑4 (IGFBP‑4) was reported to be associated with prognosis in several types of cancer; however, to the best of our knowledge, whether it is correlated with lung cancer has yet to be reported. In the present study, 102 pairs of lung cancer tissues and surrounding non‑cancerous tissues (SNCTs) were collected. The IGFBP‑4 levels in tissues were detected with immunohistochemistry. The relevance of IGFBP‑4 to the survival of patients was assessed. The IGFBP‑4 gene was knocked down, and its function in the proliferation of lung cancer cells was measured. The percentage of lung cancer tissues with higher IGFBP‑4 expression than SNCTs (51.9%) was increased compared with the percentage with similar (11.76%) or lower (36.27%) IGFBP‑4 expression. Patients with higher IGFBP‑1 expression exhibited a shorter median survival time. IGFBP‑1 was associated with metastasis, lung cancer stages and malignancy, but not with age, sex or tumor size. Lung cancer cells with stably knocked down IGFBP‑4 showed an inhibitory proliferation rate. The present study identified that IGFBP‑4 was adversely associated with the prognosis of lung cancer patients. IGFBP‑4 knockdown prohibited lung cancer cell growth. The present study provides a potential marker for lung cancer diagnosis and a possible target for lung cancer therapy.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Xiao, Y., Zhu, S., Yin, W., Liu, X., & Hu, Y. (2017). IGFBP‑4 expression is adversely associated with lung cancer prognosis. Oncology Letters, 14, 6876-6880. https://doi.org/10.3892/ol.2017.7014
MLA
Xiao, Y., Zhu, S., Yin, W., Liu, X., Hu, Y."IGFBP‑4 expression is adversely associated with lung cancer prognosis". Oncology Letters 14.6 (2017): 6876-6880.
Chicago
Xiao, Y., Zhu, S., Yin, W., Liu, X., Hu, Y."IGFBP‑4 expression is adversely associated with lung cancer prognosis". Oncology Letters 14, no. 6 (2017): 6876-6880. https://doi.org/10.3892/ol.2017.7014